Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you!
Honest Question - How does this preliminary phase I data compare to that of something like Avastin when it was at a similar stage? Thanks!
Jake, last week you were pretty upbeat and buying more based upon speaking with management and others "in the know" who were indicating that good things were in the works. Any reason other than SP that you seem to be changing your mind? Thanks.
Having someone from management or the BOD purchase a substantial amount of shares on the open market would certainly help to bring some stability in here. If they cared and believed in what they have been saying, they would make it happen (IMO).
It took nearly 40 minutes for my buy order of a measly 1500 shares at $1.05 to get filled today around mid-day. I find it curious that it took so long, yet the price was driven down substantially later in the day.
Jake - respect your opinion as I followed you a great deal with SNIC. We have heard the accumulation story here for quite some time. Any thoughts as to when we get some upward movement in SP? Also in terms of your fund contact - is long term 1 year, 3 years, 5 years? And finally, did this contact comment on management or the hx. of offshore financing?
Falconer - I have held and added to this thing for over 2 years now. I have heard the "shaking weak hands" and "panic selling" thing all the way down from $1.99. At some point, you really need to begin to question whether PPHM has the goods......
If they have positive news, now would be the time to release it. Can't believe that we are going to make a new 52 week low.
Why is EVERYTHING so secret with this company??? "Licensee wishes to remain anonymous".........peregrine "EXPECTS" to receive royalties....why not WILL receive royalties? Further terms of the deal not revealed.....WHY THE HELL NOT????? It seems every other pharma touts the terms and potential of their deals. Still long, but getting very frustrated.
All the speculation is great as well as the "science posts". However, news is LONG overdue. I recall management stating that there would be updates along the way ala "continuous news flow". This is getting old quickly.
Jake
Do you still have confidence management can deliver over the next 6-12 months?
Rick, LOL...next year!!
Happy Holidays to you and yours as well!
Ran ENMD before most recent Pipe.
Enough with the Mouse Data
Hate to say it, but the share price is going nowhere until one of two things happen - they release solid human data and/or find a new sugar daddy other than UU.
C.E. Unterberg, Towbin Conference.
Pure speculation on my part - However, PPHM announced their participation at this conference rather late in the game - literally days before the conference. I find the timing curious given Godofsky's presentation earlier in the day. Perhaps we get either initiation of coverage or even better a financing deal from Unterberg, Towbin's Investment Banking arm. Probably just wishfull thinking on my part.
Not a lot new coming out of SHM
I must admit thatI just don't get it. I believed, based upon information from Peregrine, that Cotara was in Phase II/III. Now it is in phase I in India??? Been in PPHM nearly 2 years now and it is getting harder and harder to ignore the likes of Ricardo. Any insight would be appreciated.
Bad data - sorry.
According to Merrill Lynch - 37 block trades today in excess of 10,000 shares. I have not seen that in PPHM in a while...bodes well imo.
Well, well, well....let's see how the bunny spins this one. LMAO
Dr. Thorpe "A GROWING BODY of preclinical and CLINICAL data indicates that therapies targeting PS have SIGNIFICANT potential as novel immunotherapeutics to treat cancer and VIRAL infections". Steven King "As our lead anti-PS agent bavituximab advances in CLINICAL STUDIES for the treatment of cancer and hepatitis C infection, we are INCREASINGLY enthusiastic about the clinical potential of its unique mechanism".......and some think the hep C data they are seeing is not good...GET REAL. In this day and age of shareholder lawsuits and CEO's GOING TO JAIL....you really think SK is going to make a statement like that in the face of bad data...NFW!!!!!
Genentech
Personally found it interesting that SK went out of his way to mention that India trials were being conducted by the same outfit that did Avastin trials for Genentech.
Just a Feeling
Feels to me like we have a big game of chicken going on here and there are some folks waiting for the someone else to "blink". I think someone does and we get a nice run into the weekend awaiting Monday's CC. We'll see.
Conference Call
Seems to be coming rather quickly on the heels of the end of the quarter. Leads me to believe they are preparing to release some favorable news. We shall see.